NEXCAR 19

Doctors perform India’s first allogenic CAR-T surgery

This brings new hopes for patients with solid organ tumours. Currently, the CAR-T option is available for specific form of blood cancer since an indigenously developed innovation, NexCar-19, by ImmunoACT, is approved for treatment.